New research shows that despite long-standing recommendations that severely mentally ill patients who take antipsychotics undergo annual screening for diabetes and other metabolic disorders, only 30% receive such screening. A recent research letter in JAMA Internal Medicine described a retrospective …
A recent Harris Poll survey about attitudes toward mental health was conducted on behalf of the Anxiety and Depression Associations of America, American Foundation for Suicide Prevention and the National Alliance for Suicide Prevention. Over 2,000 US adults over 18 …
This week the U.S. Preventive Services Task Force posted a draft recommendation statement and draft evidence review on screening for depression in adults. Both are available for review and public comment from July 28 through August 24, 2015. In this …
A new report by the National Academy of Medicine, titled, “Psychosocial Interventions for Mental and Substance Use Disorders: A Framework for Establishing Evidence-Based Standards” highlights the need to strengthen evidence on the effectiveness of psychosocial interventions, and to …
Research published in JAMA Psychiatry demonstrated that long-acting, injectable, second-generation antipsychotic medication has tremendous potential to bring clinical stability to persons with first-episode schizophrenia. According to the authors, “long-acting medications are rarely used following a first episode of schizophrenia.”
Patients …
A meta-analysis of clinical trial data published this week in JAMA Internal Medicine suggests that risk for suicidal behavior is twice as likely when children and young adults who are diagnosed with depression are given antidepressants compared to placebo. A …
A new study published in JAMA Psychiatry evaluated retrospective and cross-sectional surveys of reported statistics of mental health disorders and compared those results with reports of physical disorders. Interviews of 1071 adults who participated in the Baltimore Epidemiologic Catchment Area …
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders has been published in the American Journal of Psychiatry. The task force commented that there is “striking incongruity between the wide use of …
